• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE Back to Search Results
Model Number 9-ASD-015
Device Problem Extrusion (2934)
Patient Problems Erosion (1750); Tachycardia (2095); Cardiac Tamponade (2226); No Code Available (3191); Pericardial Effusion (3271)
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
A patient with a complex medical history was implanted with a 15mm amplatzer septal occluder (aso) on (b)(6) 2015 secondary to increasing dyspnea and hypoxemia.Pre-implant, the defect was balloon-sized to 14mm before "stop flow" was achieved.Follow-up echo on (b)(6) 2015, looked satisfactory.On (b)(6) the patient presented to the emergency room with presyncopal episodes and tachycardia at which point a ct diagnosed a pericardial effusion.The patient was transferred to (b)(6) where a tte confirmed the effusion and the patient was sent to surgery.Cardiac tamponade was present and pericardiocentesis was performed with approximately 200ml of sanguineous fluid removed.The aso was explanted and the erosion to the atrial roof was repaired, along with a patch closure asd was performed.
 
Manufacturer Narrative
(b)(4).The results of this investigation concluded the aso was covered in a mucus-like material that made gross, dimensional, and functional analysis difficult.A review of the device history record confirmed the occluder met all visual, dimensional, and functional specifications at the time it was manufactured, prior to shipment.There was no evidence to suggest there was an intrinsic defect, as supported by review of the valve's device history record.The cause of the reported event remains unknown.The event was reviewed by the sjm erosion board who confirmed that erosion occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
CARDIAC OCCLUSION DEVICE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key5168355
MDR Text Key28936452
Report Number2135147-2015-00128
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/07/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/22/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date07/31/2017
Device Model Number9-ASD-015
Device Catalogue Number9-ASD-015
Device Lot Number1209072525
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/15/2015
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/07/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/10/2012
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age32 YR
Patient Weight22
-
-